Correlation of HER1/EGFR expression and degree of radiosensitizing effect of the HER1/EGFR-tyrosine kinase inhibitor erlotinib

Indian Journal of Biochemistry and Biophysics

Volumn 42, Issue 6, 2005, Pages 358-365

  Kim, Jae Chul ^a,b   Ali, M Aktar ^a   Nandi, Animesh ^a   Mukhopadhyay, Partha ^a   Choy, Hak ^a   Cao, Carolyn ^a   Saha, Debabrata ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b Kyungpook National University Hospital   (South Korea)

Author keywords

Apoptosis; Autophosphorylation; Cell cycle analysis; Cell lines A431; Epidermal growth factor (EGF); Erlotinib; Flow cytometric analysis; H157 and H460; HER1 EGFR expression; HER1 EGFR inhibitor; Lung cancer; Radiosensitization; Tyrosine kinase activity

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; PROTEIN KINASE INHIBITOR; QUINAZOLINE DERIVATIVE; RADIOSENSITIZING AGENT;

APOPTOSIS; ARTICLE; CELL CULTURE; CELL CYCLE; DRUG ANTAGONISM; DRUG EFFECT; HUMAN; LUNG TUMOR; METABOLISM; PHOSPHORYLATION; RADIATION EXPOSURE; TUMOR CELL LINE;

APOPTOSIS; CELL CYCLE; CELL LINE, TUMOR; HUMANS; LUNG NEOPLASMS; PHOSPHORYLATION; PROTEIN KINASE INHIBITORS; QUINAZOLINES; RADIATION-SENSITIZING AGENTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; TUMOR CELLS, CULTURED;

EID: 33745494999     PISSN: 03011208     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Alroy I & Yarden Y (1997) FEBS Lett 410, 83-86
2. Ullrich A & Schlessinger J (1990) Cell 61, 203-212
3. Woodburn J R (1999) Pharmacol Ther 82, 241-250
4. Schlessinger J (1988) Biochemistry 27, 3119-3123
5. Carpenter G (1987) Annu Rev Biochem 56, 881-914
6. Gullick W J Br (1991) Med Bull 47, 87-98
7. Salomon D S, Brandt R, Ciardiello F & Normanno N (1995) Crit Rev Oncol Hematol 19, 183-232
8. Shin D M, Ro J Y, Hong W K & Hittelman W N (1994) Cancer Res 54, 3153-3159
9. Lemoine N R, Hughes C M & Barton C M (1992) J Pathol 166, 7-12
10. Messa C, Russo F, Caruso M G & Di Leo A (1998) Acta Oncol 37, 285-289
11. Sobol R E, Astarita R W & Hofeditz C (1987) J Natl Cancer Inst 79, 403-407
12. Pastorino U, Andreola S & Tagliabue E (1997) J Clin Oncol 15, 2858-2865
13. Harari P M & Huang S M (2001) Int J Radiat Oncol Biol Phys 49, 427-433
14. Cohen M H, Williams G, Sridhara R, Chen G & Pazdur R (2003) Oncologist 8, 303-306
15. Azemar M, Schmidt M, Arlt F, Kennel P, Brandt B, Papadimitriou A, Groner B & Wels W (2000) Int J Cancer 86, 269-275
16. Rubin G, Chakraborty A, Melhem M F, Zeng Q & Tweardy D J (1997) Oncogene 15, 409-416
17. Kwok T T & Sutherland R M (1989) J Natl Cancer Inst 81, 1020-1024
18. Kwok T T & Sutherland R M (1991) Br J Cancer 64, 251-254
19. Akimoto T, Hunter N R, Buchmiller L, Mason K, Ang K K & Milas L (1999) Clin Cancer Res 5, 2884-2890
20. Wollman R, Yahalom J, Maxy R, Pinto J & Fuks Z (1994) Int J Radiat Oncol Biol Phys 30, 91-98
21. Ang K K, Berkey B A & Tu X (2002) Cancer Res 62, 7350-7356
22. Mendelsohn J (1997) Clin Cancer Res 3, 2703-2707
23. Huang S M, Bock J M & Harari P M (1999) Cancer Res 59, 1935-1940
24. Bandyopadhyay D, Mandal M, Adam L, Mendelsohn J & Kumar R (1998) J Biol Chem 273, 1568-1573
25. Peng D, Fan Z, Lu Y, DeBlasio T, Scher H & Mendelsohn J (1996) Cancer Res 56, 3666-3669
26. Perrotte P, Matsumoto T & Inoue K (1999) Clin Cancer Res 5, 257-265
27. Krishan A (1975) J Cell Biol 66, 188-193
28. Ciardiello F, De Vita F, Orditura M, De Placido S & Tortora G (2003) Expert Opin Emerg Drugs 8, 501-514
29. Hidalgo M, Siu L L & Neumanitis J (2001) J Clin Oncol 19, 3267-3279
30. Finkler N, Gordon A & Crozier M (2001) Proc Am Soc Clin Oncol 20, 208a (Abstr 831)
31. Pérez-Soler R, Chachoua A & Huberman M (2003) Proc World Conf Lung Cancer, Abstr 611
32. Soulieres D, Senzer N N, Vokes E E, Hidalgo M, Agarwala S S & Siu L L (2004) J Clin Oncol 22, 77-85
33. Grunwald V & Hidalgo M (2003) Adv Exp Med Biol 532, 235-246
34. Huang S M & Harari P M (2000) Clin Cancer Res 2000 6, 2166-2174
35. Huang S M, Li J, Armstrong E A & Harari P M (2002) Cancer Res 62, 4300-4306
36. Milas L, Mason K & Hunter N (2000) Clin Cancer Res 6, 701-708
37. Bianco C, Bianco R & Tortora G (2000) Clin Cancer Res 6, 4343-4350
38. Raben D, Helfrich B, Chan D, Johnson G & Bunn P A Jr (2002) Semin Oncol 29, 37-46
39. Williams K J, Telfer BA, Stratford I J & Wedge S R (2002) Br J Cancer 86, 1157-1161
40. Chinnaiyan P, Huang S, Armstrong E & Harari P M (2003) Int J Radiat Oncol Biol Phys 57, S294
41. Janmaat M L, Kruyt F A, Rodriguez J A & Giaccone G (2003) Clin Cancer Res 9, 2316-2326
42. Bianco R, Shin I & Ritter C A (2003) Oncogene 22, 2812-2822
43. Soria J C, Lee H Y & Lee J I (2002) Clin Cancer Res 8, 1178-1184
44. Magne N, Fischel J L & Dubreuil A (2002) Br J Cancer 86, 1518-1523
45. Park D J, Wilczynski S P, Paquette R L, Miller C W & Koeffler H P (1994) Oncogene 9, 205-210
46. Yeudall W A, Paterson I C, Patel V & Prime S S (1995) Eur J Cancer B Oral Oncol 31B, 136-143
47. Lai S L, Perng R P & Hwang J (2000) J Biomed Sci 7, 64-70
48. Kim J C, Saha D, Cao Q & Choy H (2004) Radiother Oncol 71, 213-221
49. Chinnaiyan P, Huang S, Vallabhaneni G, Armstrong E Varambally S, Tomlins S A, Chinnaiyan A M & Harari P M (2005) Cancer Res 65, 3328-3335
50. Shintani S, Li C & Mihara M (2003) Int J Cancer 107, 1030-1037
51. Liang K, Ang K K, Milas L, Hunter N & Fan Z (2003) Int J Radiat Oncol Biol Phys 57, 246-254